Received Nov 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | — | IM |
flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (flu) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) dosage was changed to 1 dosage form. In 2021, the patient experienced INFLUENZA (flu). In 2021, INFLUENZA (flu) had resolved. No concomitant medication was reported. Patient had 4 vaccines since they started. She received her first one in Feb-2021 and then went back in March as it was 2 doses but in total since then, 4 doses. Every single vaccine she received was a Moderna product. Patient had the vaccine several times and after 24 hours she had major side effects. She felt like she had the flu for 24 hours. She gets severe body aches and a headache. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. This case was linked to MOD-2025-791110 (Patient Link).